0001209191-16-089827.txt : 20160106 0001209191-16-089827.hdr.sgml : 20160106 20160106161859 ACCESSION NUMBER: 0001209191-16-089827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151216 FILED AS OF DATE: 20160106 DATE AS OF CHANGE: 20160106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRINT PAUL C CENTRAL INDEX KEY: 0001236548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 161327046 MAIL ADDRESS: STREET 1: 3030 CALLAN RD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-16 0 0001505512 Regulus Therapeutics Inc. RGLS 0001236548 GRINT PAUL C C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS CT., #210 SAN DIEGO CA 92121 1 1 0 0 President & CEO Stock Option (Right to Buy) 7.58 2015-12-16 4 A 0 30000 0.00 A 2015-12-16 2024-06-15 Common Stock 30000 30000 D On June 16, 2014, the reporting person was granted an option to purchase 30,000 shares of common stock. The option vests only upon achievement of a performance-based milestone. The performance criteria were met, resulting in vesting of the option. Upon achievement of the milestone, fifty percent of the shares immediately vest with the remaining shares vesting over the 24 month period following the vesting commencement date, subject to the reporting person's continuous service to Regulus. Christopher Aker, Attorney-in-Fact 2016-01-06